Background Extracorporeal photopheresis (ECP) is a leukapheresis‐based cellular therapy
that is used with increasing frequency worldwide to treat various T‐cell‐mediated diseases …

Описан новый иммунотерапевтический метод экстракорпоральная фотохимиотерапия.
Освещены вопросы, касающиеся его применения при Т-клеточной лимфоме кожи и …

Extracorporeal Photopheresis (ECP) is a cellular immunotherapy frequently used for steroid‐
refractory graft‐versus‐host disease (GVHD). Chronic GVHD (cGVHD), response to ECP is …

Background and objective Extracorporeal photopheresis (ECP) is the most represented cell
therapy for treatment of cutaneous T‐cell lymphoma, graft‐versus host disease and organ …

Background To evaluate the efficacy of extracorporeal photopheresis (ECP) in
noncutaneous T-cell lymphoma and large granular lymphocytes leukemia (LGL). Patients …

There has been a dramatic increase in the incidence of Crohn's disease over the last two to
three decades worldwide, which has affected both the developed world and increasingly …

79 Extracorporeal photopheresis (ECP) is a therapeutic procedure currently used for
immune 80 modulation in lung transplant patients with chronic allograft rejection. During …

Background Despite major advances in rheumatoid arthritis outcome, not all patients
achieve remission, and there is still an unmet need for new therapeutic approaches. This …

Extracorporeal photopheresis (ECP) is an established therapy for cutaneous T-cell
lymphoma (CTCL). The objective of this study was to further explore the clinical efficacy of …

Acute graft-versus-host disease (aGvHD) continues to be a major obstacle to allogeneic
haematopoietic stem cell transplantation. Thymic damage secondary to aGvHD along with …